![Bradlee Heckmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Bradlee Heckmann
Sociétés | Poste | Début | Fin |
---|---|---|---|
Asha Therapeutics LLC
![]() Asha Therapeutics LLC Pharmaceuticals: OtherHealth Technology Asha Therapeutics LLC is an American life sciences company that specializes in precision drug design using its Prism™ technology to create curative therapeutics for diseases with high unmet medical needs in neurology, oncology, and infectious disease. Asha Therapeutics is located in the US. The company's lead therapeutic programs, Asha-624 and Asha-091, are expected to enter clinical trials by mid-2024 and are disease-modifying therapeutics for indications in amyotrophic lateral sclerosis, Parkinson's disease, and ME/CFS and long COVID, respectively. | Directeur Technique/Scientifique/R&D | - | - |
Fondateur | - | - |
Historique de carrière de Bradlee Heckmann
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Asha Therapeutics LLC
![]() Asha Therapeutics LLC Pharmaceuticals: OtherHealth Technology Asha Therapeutics LLC is an American life sciences company that specializes in precision drug design using its Prism™ technology to create curative therapeutics for diseases with high unmet medical needs in neurology, oncology, and infectious disease. Asha Therapeutics is located in the US. The company's lead therapeutic programs, Asha-624 and Asha-091, are expected to enter clinical trials by mid-2024 and are disease-modifying therapeutics for indications in amyotrophic lateral sclerosis, Parkinson's disease, and ME/CFS and long COVID, respectively. | Health Technology |
- Bourse
- Insiders
- Bradlee Heckmann
- Expérience